Nature Communications (May 2017)

Selective BET bromodomain inhibition as an antifungal therapeutic strategy

  • Flore Mietton,
  • Elena Ferri,
  • Morgane Champleboux,
  • Ninon Zala,
  • Danièle Maubon,
  • Yingsheng Zhou,
  • Mike Harbut,
  • Didier Spittler,
  • Cécile Garnaud,
  • Marie Courçon,
  • Murielle Chauvel,
  • Christophe d’Enfert,
  • Boris A. Kashemirov,
  • Mitchell Hull,
  • Muriel Cornet,
  • Charles E. McKenna,
  • Jérôme Govin,
  • Carlo Petosa

DOI
https://doi.org/10.1038/ncomms15482
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 15

Abstract

Read online

BET proteins bind chromatin through their bromodomains (BDs) to regulate transcription and chromatin remodelling. Here, the authors show that the BET protein Bdf1 is essential for the fungal pathogenCandida albicans, and report compounds that inhibit the Bdf1 BDs with high selectivity over human BDs.